血清因子对预测妊娠晚期感染GBS患者妊娠结局的临床价值OA
Clinical value of serum factors in predicting pregnancy outcomes in patients infected with group B streptococcus(GBS)during the third trimester of pregnancy
目的 探究血清淀粉样蛋白A(SAA)、可溶性髓样细胞触发型受体-1(sTREM-1)、可溶性白细胞分化抗原14亚型(sCD14-ST)联合预测妊娠晚期B族链球菌(GBS)感染患者妊娠结局的临床价值.方法 根据患者妊娠结局将2022年12月—2023年12月于秦皇岛市妇幼保健院就诊的妊娠晚期GBS感染患者(148例)分为不良组(72例)和良好组(76例),另选同期148例妊娠晚期健康孕妇为对照组.比较血清中SAA、sTREM-1、sCD14-ST的水平,多因素Logistic回归分析影响因素,受试者操作特征曲线分析预测价值.结果 与对照组比较,观察组血清SAA(132.79±14.57 vs 72.55±7.83 mg·L-1)、sTREM-1(3.39±1.05 vs 1.46±0.41 ng·L-1)、sCD14-ST(318.17±32.59 vs 223.25±23.64 ng·L-1)水平均明显升高(P<0.05);与良好组比较,不良组血清SAA(140.28±15.46 vs 125.69±13.73 mg·L-1)、sTREM-1(3.89±1.24 vs 2.92±0.87 ng·L-1)、sCD14-ST(336.27±33.79 vs 301.02±31.45 ng·L-1)水平明显升高(P<0.05);血清SAA、sTREM-1、sCD14-ST水平预测感染GBS孕妇发生不良妊娠结局的曲线下面积分别为0.757,0.813,0.807,三者联合预测的曲线下面积为0.911,优于各自单独预测(Z三者联合-SAA=3.620、Z三者联合-sTREM-1=3.044、Z三者联合-sCD14-ST=3.825,P值分别为0.000、0.002、0.000).结论 SAA、sTREM-1、sCD14-ST水平在妊娠晚期感染GBS患者血清中均上调,三者联合对妊娠晚期感染GBS患者发生不良妊娠结局有更高的预测价值.
Objective To explore the clinical value of serum amyloid A(SAA),soluble myeloid cell trigger receptor-1(sTREM-1),and soluble leukocyte differentiation antigen 14 subtype(sCD14-ST)in predicting pregnancy outcomes in late pregnancy patients with group B streptococcus(GBS)infection.Methods Patients with late-term GBS infection treated at Qinhuangdao Maternity and Child Healthcare Hospital from Decem-ber 2022 to December 2023(n=148)were categorized into an adverse group(n=72)and a favorable group(n=76)based on pregnancy outcomes.Additionally,148 healthy late-term pregnant women from the same period were selected as the control group.The levels of SAA,sTREM-1,and sCD14-ST in serum were com-pared.Multivariate logistic regression analysis was made of influencing factors;receiver operator characteris-tic curve analysis predicted the relevant value.Results Compared with the control group,the observation group had significantly higher levels of serum SAA(132.79±14.57 vs 72.55±7.83 mg·L-1),sTREM-1(3.39±1.05 vs 1.46±0.41 ng·L-1),and sCD14-ST(318.17±32.59 vs 223.25±23.64 ng·L-1,P<0.05).Compared with the good outcome group,the serum SAA(140.28±15.46 vs 125.69±13.73 mg·L-1),sTREM-1(3.89±1.24 vs 2.92±0.87 ng·L-1),and sCD14-ST(336.27±33.79 vs 301.02±31.45 ng·L-1)levels were significantly increased in the adverse outcome group(P<0.05).The area under the curve for predicting adverse preg-nancy outcomes in GBS-infected pregnant women based on serum SAA,sTREM-1,and sCD14-ST level was 0.757,0.813,and 0.807,respectively.The combined area under the curve for these three markers was 0.911,superior to their individual predictive values(Z triple combination-SAA=3.620,Z triple combination-sTREM-1=3.044,Z triple combina-tion-sCD14-ST=3.825,P=0.000,0.002,0.000).Conclusion The levels of SAA,sTREM-1,and sCD14-ST are all upregulated in the serum of patients infected with GBS in the third trimester of pregnancy.A combination of these three markers has a higher predictive value for adverse pregnancy outcomes in patients infected with GBS in the third trimester.
张宁;胡雁琼;宋伟夫
秦皇岛市妇幼保健院 产科,河北 秦皇岛 066000秦皇岛市妇幼保健院 妇科,河北 秦皇岛 066000秦皇岛市妇幼保健院 妇科,河北 秦皇岛 066000
医药卫生
妊娠晚期B族链球菌感染血清淀粉样蛋白A可溶性髓样细胞触发型受体-1可溶性白细胞分化抗原14亚型妊娠结局血清因子预测价值
late pregnancy group B streptococcal infectionserum amyloid Asoluble triggering receptor ex-pressed on myeloid cells-1soluble leukocyte differentiation antigen 14 subtypepregnancy outcomesserum factorspredictive value
《兰州大学学报(医学版)》 2026 (7)
51-57,7
秦皇岛市科学技术研究与发展计划项目(202301A255)
评论